Tenet Healthcare appoints Vineeta Agarwala to its board of directors [Photo: Tenet Healthcare]
Dallas-based healthcare company Tenet Healthcare Corporation has appointed industry leader Vinita Agarwala, MD, to its Board of Directors, effective immediately.
“We are pleased to welcome Dr. Vinita Agarwala to the Tenet Board of Directors,” Saum Sutaria, MD, Tenet Chairman and CEO, said in a statement. “Vineeta is a healthcare leader in her own right. Her expertise in innovative technologies, including the application of artificial intelligence, will strengthen our governance in the rapidly evolving healthcare market.”
Tenet said Agarwala will serve on the quality, compliance and ethics committee and the human resources committee, increasing the size of the board to 13 directors.
She is a general partner at Andreessen Horowitz (a16z) and leads investments in the firm's Bio+Health Fund across biotechnology and digital health, Tenet said. Agarwala is focused on partnering with companies that leverage unique technologies and datasets to advance new approaches to drug development, personalized medicine, and patient care delivery.
Agarwala's experience includes research at the prestigious Broad Institute for Computational Biology and Human Genetics. She completed her clinical training at Stanford University and is board certified in her internal medicine practice.
Tenet is a diversified healthcare services company whose care delivery network includes United Surgical Partners International, the nation's largest outpatient platform, and operates or owns more than 480 ambulatory surgical centers and surgical hospitals. I have.
The Company operates 61 acute care and specialty hospitals in Manila, Philippines, approximately 110 other outpatient facilities, a network of major employed physicians, and global business centers.
Conifer Health Solutions, a subsidiary of Tenet, provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other customers.
Please put it on the list.
Dallas innovates every day.
Sign up to stay up-to-date on what's new and next in Dallas-Fort Worth, every day.
Read next
-
Meloni, Google CDO and Kanary Director, said: “Data is key to sustaining DEIB’s continued commitment and dedication, so Kanarys is leading the way in establishing a quantifiable DEIB strategy that can be used in any work environment. “Thanks to a data-centric methodology aimed at building a more just future for the world,” said Parker.
-
Tenet Healthcare Corporation of Dallas announced that former U.S. Sen. Roy Blunt has been appointed to the Tenet Board of Directors. Mr. Brandt serves as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social and Governance Committee. The company announced that his appointment expands the number of board members to 12, of whom 11 are independent directors. “We are pleased to welcome Senator Roy Blunt as a new member of our board of directors,” Tenet CEO Dr. Saum Sutaria said in a statement. “With over 25 years of legislative experience, Roy’s expertise in addressing public policy and cross-cutting issues is…
-
Combining two health technology innovators, Dallas-based unicorn Axxess is accelerating its efforts to revolutionize home health technology solutions for healthcare providers with the strategic acquisition of Complia Health.
-
A1 Health Ventures is a newly formed VC firm co-developed by Abundant Venture Partners and First Trust Capital Partners. Director Joe Greskowiak will join Dallas-based Prolucent's board of directors following a $4 million investment to drive Prolucent's “continuous product innovation.”
-
Dallas-Fort Worth is well known for its technology expertise. Nowadays, where technology and life sciences meet, biotechnology is recognized as a place of convergence that fosters the rapid growth of ecosystems. Industry leaders attribute this success to the unique combination of the region's outstanding technology talent pool and cutting-edge developments in life sciences. The region has seen breakthroughs in fields ranging from genetic engineering to cancer treatment to environmental restoration. Dr. Hubert Zajicek, CEO, partner and co-founder of Health Wildcatters, is one of a group of local biotech leaders who recognize Dallas' strengths in technology and its role.
